
Maharashtra FDA Flags 2,841% IV Set Margin, Demands Price Rationalisation
The story in brief
Maharashtra FDA Commissioner Tukaram Mundhe flagged a 2,841% margin on IV sets after a market survey revealed a stark price gap. The survey highlighted significant disparities in hospital consumables, with IV sets bought for Rs 11.05 but sold at Rs 325. The FDA seeks inclusion of medical devices under the DPCO framework to address the pricing-policy gap.